⌘K

Login Start Free

Home/Filings/4/0001415889-24-008320

4//SEC Filing

Vig Pamela 4

Accession 0001415889-24-008320

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 5:44 PM ET

Size

5.5 KB

Accession

0001415889-24-008320

Insider Transaction Report

Form 4

Period: 2023-01-09

Mirum Pharmaceuticals, Inc.MIRM

Chief Scientific Officer

Transactions

Sale
Common Stock
2023-01-09$20.62/sh−1,379$28,438→ 27,312 total

Holdings

Common Stock
(indirect: By Trust)
75,000

Footnotes (1)

[F1]Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.

Documents

1 file

4
form4-03182024_090327.xmlPrimary

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780069

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 5:44 PM ET
Size: 5.5 KB

View on SEC.gov